Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership Editorial


Authors: Nolte, F. S.; Babady, N. E.; Buchan, B. W.; Capraro, G. A.; Graf, E. H.; Leber, A. L.; McElvania, E.; Yao, J. D. C.
Title: Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership
Abstract: Clinical molecular laboratory professionals are at the frontline of the response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, providing accurate, high-quality laboratory results to aid in diagnosis, treatment, and epidemiology. In this role, we have encountered numerous regulatory, reimbursement, supply-chain, logistical, and systems challenges that we have struggled to overcome to fulfill our calling to provide patient care. In this Perspective from the Association for Molecular Pathology Infectious Disease Subdivision Leadership team, we review how our members have risen to these challenges, provide recommendations for managing the current pandemic, and outline the steps we can take as a community to better prepare for future pandemics. © 2020 Association for Molecular Pathology and American Society for Investigative Pathology
Journal Title: Journal of Molecular Diagnostics
Volume: 22
Issue: 8
ISSN: 1525-1578
Publisher: Elsevier Science, Inc.  
Date Published: 2020-08-01
Start Page: 968
End Page: 974
Language: English
DOI: 10.1016/j.jmoldx.2020.06.003
PUBMED: 32565306
PROVIDER: scopus
PMCID: PMC7303040
DOI/URL:
Notes: Review -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ngolela Esther Babady
    171 Babady